Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

The market is wrong about $HIMS. $HIMS is moving towards a $PLTR-style, non-linear value creation even that brings the world's most valuable subscription service to the life.

Antonio Linares

117,219 subscribers

44,537 просмотров • 6 месяцев назад •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

biology<>AI is going to deliver most of the returns in the stock market I went long $pltr at $7, $amd at $4.2: this is way, way bigger breaks down into two buckets: read: $rxrx $naut $tem $cai $hims write: $ibrx $inkt $ngen $pbls most value accrues to the Ontology: $HIMS

biology<>AI is going to deliver most of the returns in the stock market I went long $pltr at $7, $amd at $4.2: this is way, way bigger breaks down into two buckets: read: $rxrx $naut $tem $cai $hims write: $ibrx $inkt $ngen $pbls most value accrues to the Ontology: $HIMS

Antonio Linares

77,485 просмотров • 2 месяцев назад

Jeff Bezos says that if you have a 10% chance of making a 100x, you should take that bet every single time. This is the case with $HIMS. Down ~75% from its highs, ~$4B market cap, and a P/S ratio below 2. $HIMS trades as if it’s destined to fail — all the pessimism is already priced in. Once you realize $HIMS is not a GLP-1 company, but a platform, with new verticals launching faster and faster, it’s hard not to see $HIMS as the most asymmetric bet in the market.

Jeff Bezos says that if you have a 10% chance of making a 100x, you should take that bet every single time. This is the case with $HIMS. Down ~75% from its highs, ~$4B market cap, and a P/S ratio below 2. $HIMS trades as if it’s destined to fail — all the pessimism is already priced in. Once you realize $HIMS is not a GLP-1 company, but a platform, with new verticals launching faster and faster, it’s hard not to see $HIMS as the most asymmetric bet in the market.

Daniel

142,243 просмотров • 6 месяцев назад

$HIMS is tracking towards a $PLTR moment, as it turns longevity into a computation problem. It's going to understand exactly what is happening inside the body of any subscriber at the molecular level and fix illness before it even happens.

$HIMS is tracking towards a $PLTR moment, as it turns longevity into a computation problem. It's going to understand exactly what is happening inside the body of any subscriber at the molecular level and fix illness before it even happens.

Antonio Linares

34,960 просмотров • 9 месяцев назад

The decision by $LLY and $NVO to offer their drugs on $HIMS proves the power of its platform. $HIMS is like $AMZN and $NFLX in the early stages. The vision of Andrew Dudum is taking shape. Over time, more drugs will be added to the platform. The reason is simple: with 2.5M subscribers, $HIMS has built the largest health distribution platform in the world. If you want maximum reach, you go where the users are. That’s $HIMS. At a $6B market cap, $HIMS remains one of the biggest opportunities in the market.

The decision by $LLY and $NVO to offer their drugs on $HIMS proves the power of its platform. $HIMS is like $AMZN and $NFLX in the early stages. The vision of Andrew Dudum is taking shape. Over time, more drugs will be added to the platform. The reason is simple: with 2.5M subscribers, $HIMS has built the largest health distribution platform in the world. If you want maximum reach, you go where the users are. That’s $HIMS. At a $6B market cap, $HIMS remains one of the biggest opportunities in the market.

Daniel

51,442 просмотров • 4 месяцев назад

everyone gave up on $HIMS in february 2026 the stock is up ~3X since $hims is a not a GLP-1 company, but a Healthcare Ontology $2,000/share intrinsic value by the year 2030

everyone gave up on $HIMS in february 2026 the stock is up ~3X since $hims is a not a GLP-1 company, but a Healthcare Ontology $2,000/share intrinsic value by the year 2030

Antonio Linares

104,041 просмотров • 2 месяцев назад

My reply to Joseph Carlson, about the proof of my $AMD, $TSLA, $PLTR, $SPOT and $HIMS extraordinarily succesful picks.

My reply to Joseph Carlson, about the proof of my $AMD, $TSLA, $PLTR, $SPOT and $HIMS extraordinarily succesful picks.

Antonio Linares

479,836 просмотров • 1 год назад

$HIMS is about to trigger the biggest healthcare shift in 100 years

$HIMS is about to trigger the biggest healthcare shift in 100 years

Antonio Linares

30,380 просмотров • 8 месяцев назад

everyone gave up on $hims in february 2026 the stock is up ~3x since $hims isn’t a glp-1 company. it’s a healthcare ontology. $2,000/share intrinsic value by 2030

everyone gave up on $hims in february 2026 the stock is up ~3x since $hims isn’t a glp-1 company. it’s a healthcare ontology. $2,000/share intrinsic value by 2030

Antonio Linares

53,475 просмотров • 1 месяц назад

This Stock is Next to make NEW$millionaires‼️ "the MOVE will SHOCK the market" $HIMS $AMD $MU $NFLX $CELH

This Stock is Next to make NEW$millionaires‼️ "the MOVE will SHOCK the market" $HIMS $AMD $MU $NFLX $CELH

Jeremy Lefebvre

53,150 просмотров • 16 дней назад

$hims dropped 50%+ four times in 2025. the stock is down 80% from the highs. this stock has broken most investors. meanwhile, this is who real long-term $hims holders have become:

$hims dropped 50%+ four times in 2025. the stock is down 80% from the highs. this stock has broken most investors. meanwhile, this is who real long-term $hims holders have become:

Antonio Linares

38,154 просмотров • 4 месяцев назад

$hims is back at pre lawsuit levels. the bear case has nothing left. $nvo is now a key partner. peptides are going mainstream, and $hims is the largest healthcare d2c platform on earth, the only one with a verticalised peptide supply chain. $hims here is $amd at $75 last year.

$hims is back at pre lawsuit levels. the bear case has nothing left. $nvo is now a key partner. peptides are going mainstream, and $hims is the largest healthcare d2c platform on earth, the only one with a verticalised peptide supply chain. $hims here is $amd at $75 last year.

Antonio Linares

64,503 просмотров • 1 месяц назад

$HIMS Over 100+ requests for me to update $HIMS. Here's the exact video on when to buy and what to expect moving forward. Short-term might be ugly. Long-term will (most likely) head to all-time highs.

$HIMS Over 100+ requests for me to update $HIMS. Here's the exact video on when to buy and what to expect moving forward. Short-term might be ugly. Long-term will (most likely) head to all-time highs.

StockWhale

66,590 просмотров • 1 год назад

Chinese media : Jeon Jungkook BTS is the most valuable "Korea's Shi Yong Yi" or the most valuable korean man with title forever number 1 in the world or world's eternal 1st. His life story is so incredible that even novelists wouldn't dare to write it. #JUNGKOOK #전정국

Chinese media : Jeon Jungkook BTS is the most valuable "Korea's Shi Yong Yi" or the most valuable korean man with title forever number 1 in the world or world's eternal 1st. His life story is so incredible that even novelists wouldn't dare to write it. #JUNGKOOK #전정국

Maddie 💟 XIAO ZHAN IS FREE

27,026 просмотров • 9 месяцев назад

🚨 TBPN TALKING ABOUT $HIMS CEO ANDREW DUDUM John Coogan: "Who's the most underrated (or greatest) entrepreneur of all-time?" Nate Bosshard: "In the last decade, Andrew Dudum of Hims & Hers. Fastest consumer company to go public. The only successful consumer SPAC trading at $11B. HE IS AN ABSOLUTE KILLER. He is incredibly underrated."

🚨 TBPN TALKING ABOUT $HIMS CEO ANDREW DUDUM John Coogan: "Who's the most underrated (or greatest) entrepreneur of all-time?" Nate Bosshard: "In the last decade, Andrew Dudum of Hims & Hers. Fastest consumer company to go public. The only successful consumer SPAC trading at $11B. HE IS AN ABSOLUTE KILLER. He is incredibly underrated."

Hims House

29,917 просмотров • 11 месяцев назад